Hypoxia sensing in Cryptococcus Neoformans: Biofilm-like adaptation for dormancy?

Biomedical Papers

Volumn 153, Issue 3, 2009, Pages 189-193

  Moranova, Zuzana ^a,b   Kawamoto, Susumu ^b   Raclavsky, Vladislav ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Biofilm; Cryptococcus neoformans; Dormancy; Hypoxia; Pathogenesis; Virulence

Indexed keywords

BACTERIA (MICROORGANISMS); FILOBASIDIELLA NEOFORMANS;

ADAPTATION; ARTICLE; BIOFILM; CELL HYPOXIA; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; GROWTH, DEVELOPMENT AND AGING; PATHOGENICITY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADAPTATION, PHYSIOLOGICAL; BIOFILMS; CELL HYPOXIA; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS;

EID: 70349990702     PISSN: 12138118     EISSN: 12138118     Source Type: Journal    
DOI: 10.5507/bp.2009.031     Document Type: Article

References (47)

1. Kwon-Chung KJ and Varma A. Do major species concepts support one, two or more species within Cryptococcus neoformans? FEMS Yeast Res 2006; 6:574-87.
2. Sorrell TC and Ellis DH. Ecology of Cryptococcus neoformans. Rev Iberoam Micol 1997; 14:42-3.
3. Lazera MS, Pires FD, Camillo-Coura L, Nishikawa MM, Bezerra CC, Trilles L, et al. Natural habitat of Cryptococcus neoformans var. neoformans in decaying wood forming hollows in living trees. J Med Vet Mycol 1996; 34:127-31.
4. Lazera MS, Salmito Cavalcanti MA, Londero AT, Trilles L, Nishikawa MM and Wanke B. Possible primary ecological niche of Cryptococcus neoformans. Med Mycol 2000; 38:379-83.
5. Randhawa HS, Mussa AY and Khan ZU. Decaying wood in tree trunk hollows as a natural substrate for Cryptococcus neoformans and other yeast-like fungi of clinical interest. Mycopathologia 2001; 151:63-9.
6. Botes A, Boekhout T, Hagen F, Vismer H, Swart J and Botha A. Growth and mating of Cryptococcus neoformans var. grubii on woody debris. Microb Ecol 2009; 57:757-65.
7. Ellis DH and Pfeiffer TJ. Natural habitat of Cryptococcus neoformans var. gattii. J Clin Microbiol 1990; 28:1642-4.
8. Idnurm A, Bahn YS, Nielsen K, Lin X, Fraser JA and Heitman J. Deciphering the model pathogenic fungus Cryptococcus neoformans. Nat Rev Microbiol 2005; 3:753-64.
9. Ernst JF and Tielker D. Responses to hypoxia in fungal pathogens. Cell Microbiol 2009; 11:183-90.
10. Odds FC, De Backer T, Dams G, Vranckx L and Woestenborghs F. Oxygen as limiting nutrient for growth of Cryptococcus neoformans. J Clin Microbiol 1995; 33:995-7.
11. Rodriguez-Tudela JL, Martin-Diez F, Cuenca-Estrella M, Rodero L, Carpintero Y and Gorgojo B. Influence of shaking on antifungal susceptibility testing of Cryptococcus neoformans: a comparison of the NCCLS standard M27A medium, buffered yeast nitrogen base, and RPMI-2% glucose. Antimicrob Agents Chemother 2000; 44:400-4.
12. Roberts GD, Horstmeier C, Hall M and Washington JA, 2nd. Recovery of yeast from vented blood culture bottles. J Clin Microbiol 1975; 2:18-20.
13. Huahua T, Rudy J and Kunin CM. Effect of hydrogen peroxide on growth of Candida, Cryptococcus, and other yeasts in simulated blood culture bottles. J Clin Microbiol 1991; 29:328-32.
14. Takeo K, Tanaka R, Miyaji M and Nishimura K. Unbudded G2 as well as G1 arrest in the stationary phase of the basidiomycetous yeast Cryptococcus neoformans. FEMS Microbiol Lett 1995; 129:231-5.
15. Ohkusu M, Hata K and Takeo K. Bud emergence is gradually delayed from S to G2 with progression of growth phase in Cryptococcus neoformans. FEMS Microbiol Lett 2001; 194:251-5.
16. Ohkusu M, Raclavsky V and Takeo K. Deficit in oxygen causes G(2) budding and unbudded G(2) arrest in Cryptococcus neoformans. FEMS Microbiol Lett 2001; 204:29-32.
17. Raclavsky V, Husickova V, Moranova Z, Ohkusu M, Fischer O, Precek J, et al. Growth strategy of the pathogenic yeast Cryptococcus neoformans submerged culture under different cultivation formats. Folia Microbiol (Praha) 2009; 54:349--52.
18. Raclavsky V, Pavlicek J, Novotny R, Moranova Z, Ohkusu M, Trtkova J, et al. Peculiar clusters of daughter cells observed in Cryptococcus neoformans grown in sealed microtiter plates. Folia Microbiol (Praha) 2009; 54:369-71.
19. Takeo K, Ogura Y, Virtudazo E, Raclavsky V and Kawamoto S. Isolation of a CDC28 homologue from Cryptococcus neoformans that is able to complement cdc28 temperature-sensitive mutants of Saccharomyces cerevisiae. FEMS Yeast Res 2004; 4:737-44.
20. Silver I and Erecinska M. Oxygen and ion concentrations in normoxic and hypoxic brain cells. Adv Exp Med Biol 1998; 454:7-16.
21. Chang YC, Stins MF, McCaffery MJ, Miller GF, Pare DR, Dam T, et al. Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier. Infect Immun 2004; 72:4985-95.
22. Chun CD, Liu OW and Madhani HD. A link between virulence and homeostatic responses to hypoxia during infection by the human fungal pathogen Cryptococcus neoformans. PLoS Pathog 2007; 3:e22.
23. Chang YC, Bien CM, Lee H, Espenshade PJ and Kwon-Chung KJ. Sre1p, a regulator of oxygen sensing and sterol homeostasis, is required for virulence in Cryptococcus neoformans. Mol Microbiol 2007; 64:614-29.
24. Brown MS and Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997; 89:331-40.
25. Espenshade PJ. SREBPs: sterol-regulated transcription factors. J Cell Sci 2006; 119:973-6.
26. Bengoechea-Alonso MT and Ericsson J. SREBP in signal transduction: cholesterol metabolism and beyond. Curr Opin Cell Biol 2007; 19:215-22.
27. Horton JD, Shah NA, Warrington JA, Anderson NN, Park SW, Brown MS, et al. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc Natl Acad Sci U S A 2003; 100:12027-32.
28. Hughes AL, Todd BL and Espenshade PJ. SREBP pathway responds to sterols and functions as an oxygen sensor in fission yeast. Cell 2005; 120:831-42.
29. Todd BL, Stewart EV, Burg JS, Hughes AL and Espenshade PJ. Sterol regulatory element binding protein is a principal regulator of anaerobic gene expression in fission yeast. Mol Cell Biol 2006; 26:2817-31.
30. Bahn YS, Kojima K, Cox GM and Heitman J. A unique fungal two-component system regulates stress responses, drug sensitivity, sexual development, and virulence of Cryptococcus neoformans. Mol Biol Cell 2006; 17:3122-35.
31. Lee H, Bien CM, Hughes AL, Espenshade PJ, Kwon-Chung KJ and Chang YC. Cobalt chloride, a hypoxia-mimicking agent, targets sterol synthesis in the pathogenic fungus Cryptococcus neoformans. Mol Microbiol 2007; 65:1018-33.
32. Ingavale SS, Chang YC, Lee H, McClelland CM, Leong ML and Kwon-Chung KJ. Importance of mitochondria in survival of Cryptococcus neoformans under low oxygen conditions and tolerance to cobalt chloride. PLoS Pathog 2008; 4:e1000155.
33. Inoue N, Shimano H, Nakakuki M, Matsuzaka T, Nakagawa Y, Yamamoto T, et al. Lipid synthetic transcription factor SREBP- 1a activates p21WAF1/CIP1, a universal cyclin-dependent kinase inhibitor. Mol Cell Biol 2005; 25:8938-47.
34. Nakakuki M, Shimano H, Inoue N, Tamura M, Matsuzaka T, Nakagawa Y, et al. A transcription factor of lipid synthesis, sterol regulatory element-binding protein (SREBP)-1a causes G(1) cellcycle arrest after accumulation of cyclin-dependent kinase (cdk) inhibitors. FEBS J 2007; 274:4440-52.
35. Peterson JR, Zjawiony JK, Liu S, Hufford CD, Clark AM and Rogers RD. Copyrine alkaloids: synthesis, spectroscopic characterization, and antimycotic/antimycobacterial activity of A- and B-ring-functionalized sampangines. J Med Chem 1992; 35:4069-77.
36. Agarwal AK, Xu T, Jacob MR, Feng Q, Lorenz MC, Walker LA, et al. Role of heme in the antifungal activity of the azaoxoaporphine alkaloid sampangine. Eukaryot Cell 2008; 7:387-400.
37. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR and Lappin-Scott HM. Microbial biofilms. Annu Rev Microbiol 1995; 49:711-45.
38. Donlan RM and Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15:167-93.
39. Garcia-Hermoso D, Janbon G and Dromer F. Epidemiological evidence for dormant Cryptococcus neoformans infection. J Clin Microbiol 1999; 37:3204-9.
40. Casadevall A and Perfect JR. Cryptococcus neoformans. Washington: ASM Press; 1998.
41. Fries BC, Goldman DL and Casadevall A. Phenotypic switching in Cryptococcus neoformans. Microbes Infect 2002; 4:1345-52.
42. Guerrero A, Jain N, Goldman DL and Fries BC. Phenotypic switching in Cryptococcus neoformans. Microbiology 2006; 152:3-9.
43. Stichternoth C and Ernst JF. Hypoxic adaptation by Efg1 regulates biofilm formation by Candida albicans. Appl Environ Microbiol 2009; 75:3663-72.
44. Sellam A, Al-Niemi T, McInnerney K, Brumfield S, Nantel A and Suci PA. A Candida albicans early stage biofilm detachment event in rich medium. BMC Microbiol 2009; 9:25.
45. Rossignol T, Ding C, Guida A, d'Enfert C, Higgins DG and Butler G. Correlation between biofilm formation and the hypoxic response in Candida parapsilosis. Eukaryot Cell 2009; 8:550-9.
46. Martinez LR and Casadevall A. Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro. Antimicrob Agents Chemother 2006; 50:1021-33.
47. Walsh TJ, Schlegel R, Moody MM, Costerton JW and Salcman M. Ventriculoatrial shunt infection due to Cryptococcus neoformans: an ultrastructural and quantitative microbiological study. Neurosurgery 1986; 18:373-5.